COVID‐19 in patients with hematological malignancies: A retrospective case series - Wiley

COVID‐19 in patients with hematological malignancies: A retrospective case series  Wiley

Comments

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review